Hydrosilane/Lewis acid adduct, particularly aluminum, iron, and zinc, method for preparing same, and use of said same in reactions for reducing carbonyl derivatives

US10099986B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10099986-B2
Application numberUS-201615547425-A
CountryUS
Kind codeB2
Filing dateJan 29, 2016
Priority dateJan 30, 2015
Publication dateOct 16, 2018
Grant dateOct 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is an adduct between a Lewis acid, preferably aluminum trichloride, iron trichloride, or zinc dichloride, and a hydrosilane;—a method for preparing same; and a method for for reducing, particularly, an aldehyde, a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine.

First claim

Opening claim text (preview).

The invention claimed is: 1. A pre-formed adduct between a Lewis acid selected from the salts of zinc (II), tin (II) or (IV), iron (II) or iron (III), copper (I), palladium (II), titanium (III) or (IV), bismuth (III) or aluminium (III) and a hydrosilane. 2. The adduct according to claim 1 , wherein the Lewis acid is a salt of zinc (II), a salt of iron (III), or a salt of aluminium (III). 3. The adduct according to claim 1 , wherein the hydrosilane is selected from the group selected from consisting of trialkylsilanes, tris(trimethylsilyl)silane, triphenylsilane, polymethylhydrosiloxanes (PMHS), polydimethylsiloxanes having a terminal Si—H group, a methylhydro-dimethylsiloxane copolymer, a methylhydrophenyl-methylsiloxane copolymer, a methylhydrocyanopropylsiloxane copolymer, a methylhydromethyloctylsiloxane copolymer, poly(1,2-dimethylhydrosilazane), a 1-methyl-hydrosilazane (1,2-dimethylhydrosilazane) copolymer, and methylhydrocyclosiloxane. 4. The adduct according to claim 3 , wherein the hydrosilane is selected from the group consisting of polymethylhydrosiloxane, tetramethyldisiloxane and triethylsilane. 5. The adduct according to claim 1 , further comprising another Lewis acid, a metal salt, an alcohol, or a dihalogen. 6. The adduct according to claim 5 , comprising an alcohol. 7. An adduct AlCl 3 /triethylsilane/isopropanol in a molar ratio of 0.3:1:0.6. 8. An adduct FeCl 3 /triethylsilane/iso-propanol or FeCl 3 /triethylsilane /tert-butanol in a molar ratio of x:1:2x, where X varies from 0.01 to 1. 9. A method for performing a reaction of reduction of an aldehyde, an α,β-unsaturated aldehyde, a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine, comprising providing the adduct of claim 1 , and combining the adduct with the aldehyde, α,β-unsaturated aldehyde, ketone, α,β-unsaturated ketone, imine, or α,β-unsaturated imine. 10. The method according to claim 9 , wherein the reduction is of a ketone or an α,β-unsaturated ketone. 11. The method according to claim 9 , wherein the reduction is of a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine of formula (Ia): in which: X is O or N R a , R a being selected from the group consisting of a linear or branched alkyl having at most 12 carbon atoms, a linear or branched alkylene having at most 6 carbon atoms, a carbocyclic or heterocyclic aryl, and an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, is a single bond or a double bond, R 1 is a linear or branched alkyl radical having at most 12 carbon atoms, a linear or branched alkylene having at most 12carbon atoms, or a saturated or unsaturated cycloalkyl radical having 3 to 7 carbon atoms and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic or heterocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, R 2 is hydrogen, linear or branched alkyl having at most 12 carbon atoms, a linear or branched alkylene having at most 6carbon atoms, a carbocyclic or heterocyclic aryl, or an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, R 3 and R 4 , which are identical or different, are hydrogen, a linear or branched alkyl having at most 12 carbon atoms, a linear or branched alkylene having at most 6 carbon atoms, a carbocyclic or heterocyclic aryl, or an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, and when is a single bond, R 5 is hydrogen, a linear or branched alkyl having at most 12 carbon atoms, a linear or branched alkylene having at most 12 carbon atoms, a carbocyclic or heterocyclic aryl, or an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, and R 6 is hydrogen, a linear or branched alkyl having at most 12 carbon atoms, a linear or branched alkylene having at most 12 carbon atoms, a carbocyclic or heterocyclic aryl, or an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, or a cyclic ketone, α, β-unsaturated ketone, imine or α, β-unsaturated imine of formula (Ib): in which: n =0 or 1, X and are as defined above, R 7 is a linear or branched alkyl radical having at most 12 carbon atoms, a linear or branched alkylene having at most 12carbon atoms, or a saturated or unsaturated cycloalkyl radical having 3 to 7 carbon atoms and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic or heterocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl, aryl or cycloalkyl radicals being optionally substituted, R 9 is a hydrogen, a linear or branched alkyl radical having at most 12 carbon atoms, a linear or branched alkylene having at most 12 carbon atoms, or a saturated or unsaturated cycloalkyl radical having from 3 to 7 carbon atoms and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic or heterocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, or a CHR 12 —COOR 13 group, in which R 12 is hydrogen or a linear or branched alkyl radical having at most 12 carbon atoms, and R 13 is a linear or branched alkyl radical having at most 12 carbon atoms or a saturated or unsaturated cycloalkyl radical having from 3 to 7 carbon atoms, and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, and when is a single bond, R 8 , and R 10 , which are identical or different, are a hydrogen, a linear or branched alkyl radical having at most 12carbon atoms, a linear or branched alkylene having at most 12carbon atoms, or a saturated or unsaturated cycloalkyl radical having from 3 to 7 carbon atoms and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic or heterocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, or a CHR 12 —COOR 13 group, in which R 12 is hydrogen or a linear or branched alkyl radical having at most 12 carbon atoms, and R 13 is a linear or branched alkyl radical having at most 12 carbon atoms or a saturated or unsaturated cycloalkyl radical having from 3 to 7 carbon atoms, and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic aryl radical, R 11 is hydrogen, a linear or branched alkyl radical having at most 12 carbon atoms, a linear or branched alkylene having at most 12 carbon atoms, or a saturated or unsaturated cycloalkyl radical having from 3 to 7 carbon atoms and optionally comprising one or more heteroatoms selected from nitrogen, sulfur or oxygen atoms, a carbocyclic or heterocyclic aryl radical, an aralkyl radical, each of said alkyl, alkylene, aralkyl or aryl radicals being optionally substituted, advantageously an alkyl radical having at most 12 carbon atoms, or, when is a single bond, R 7 and R 8 are together a ═CH—R 7a group where R 7a i

Assignees

Inventors

Classifications

  • Chlorides (containing fluorine C01F7/52) · CPC title

  • with simultaneous reduction of an oxo group · CPC title

  • by hydrogenation of carbon-to-carbon double or triple bonds · CPC title

  • Halides · CPC title

  • Compounds with a Si-H linkage · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10099986B2 cover?
Disclosed is an adduct between a Lewis acid, preferably aluminum trichloride, iron trichloride, or zinc dichloride, and a hydrosilane;—a method for preparing same; and a method for for reducing, particularly, an aldehyde, a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine.
Who is the assignee on this patent?
Centre Nat Rech Scient, Univ Montpellier
What technology area does this patent fall under?
Primary CPC classification C07C45/65. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).